Literature DB >> 24625808

High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.

Anil K Chaturvedi1, Barry I Graubard1, Robert K L Pickard2, Weihong Xiao2, Maura L Gillison2.   

Abstract

We investigated the association of demographic and behavioral factors with oral human papillomavirus (HPV) load for 18 high-risk types among 211 individuals with prevalent high-risk HPV within the National Health and Nutrition Examination Survey 2009-2010. Factors independently associated with HPV load above the median included older age (odds ratio, 1.04 per year increase [95% confidence interval, 1.01-1.07]; P = .004) and intensity of current smoking (P for trend <.001). A marginally greater percentage of men than women had an HPV load above the median (55.7% vs 32.8%; P = .069), and HPV load increased marginally with increasing alcohol use (P for trend = .062). In conclusion, older age and current smoking are associated with a high oral load of high-risk HPV types among individuals with a prevalent infection. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Human papillomavirus (HPV); NHANES; oral; oropharynx; smoking; viral load

Mesh:

Year:  2014        PMID: 24625808      PMCID: PMC4110460          DOI: 10.1093/infdis/jiu116

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Viral load as a predictor of the risk of cervical intraepithelial neoplasia.

Authors:  Nicolas F Schlecht; Andrea Trevisan; Eliane Duarte-Franco; Thomas E Rohan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

2.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

3.  Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.

Authors:  Aimée R Kreimer; Christine M Pierce Campbell; Hui-Yi Lin; William Fulp; Mary R Papenfuss; Martha Abrahamsen; Allan Hildesheim; Luisa L Villa; Jorge J Salmerón; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Lancet       Date:  2013-07-02       Impact factor: 79.321

4.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.

Authors:  A M Josefsson; P K Magnusson; N Ylitalo; P Sørensen; P Qwarforth-Tubbin; P K Andersen; M Melbye; H O Adami; U B Gyllensten
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

5.  Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.

Authors:  N Ylitalo; P Sørensen; A M Josefsson; P K Magnusson; P K Andersen; J Pontén; H O Adami; U B Gyllensten; M Melbye
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

6.  Comparative response of normal and of human papillomavirus-16 immortalized human epithelial cervical cells to benzo[a]pyrene.

Authors:  A A Melikian; X Wang; S Waggoner; D Hoffmann; K El-Bayoumy
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

7.  Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Craig Meyers; Jesse Ho; Mark Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

8.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

9.  High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.

Authors:  Patti E Gravitt; Melinda Butsch Kovacic; Rolando Herrero; Mark Schiffman; Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Ana-Cecilia Rodriguez; Robert D Burk
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

10.  Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort.

Authors:  Carole Fakhry; Elizabeth Sugar; Gypsyamber D'Souza; Maura Gillison
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more
  13 in total

1.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

2.  NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men.

Authors:  Anil K Chaturvedi; Barry I Graubard; Tatevik Broutian; Robert K L Pickard; Zhen-Yue Tong; Weihong Xiao; Lisa Kahle; Maura L Gillison
Journal:  Cancer Res       Date:  2015-04-14       Impact factor: 12.701

3.  Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study.

Authors:  Ralf B Uken; Oliver Brummer; Carolin von Schubert-Bayer; Thomas Brodegger; Ingo U Teudt
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-09       Impact factor: 2.503

4.  Tobacco use and oral HPV-16 infection.

Authors:  Carole Fakhry; Maura L Gillison; Gypsyamber D'Souza
Journal:  JAMA       Date:  2014-10-08       Impact factor: 56.272

5.  Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.

Authors:  Adam Scheel; Emily Bellile; Jonathan B McHugh; Heather M Walline; Mark E Prince; Susan Urba; Gregory T Wolf; Avraham Eisbruch; Francis Worden; Thomas E Carey; Carol Bradford
Journal:  Laryngoscope       Date:  2016-06-27       Impact factor: 3.325

6.  Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.

Authors:  Eleni M Rettig; Alicia Wentz; Marshall R Posner; Neil D Gross; Robert I Haddad; Maura L Gillison; Carole Fakhry; Harry Quon; Andrew G Sikora; William J Stott; Jochen H Lorch; Christine G Gourin; Yingshi Guo; Weihong Xiao; Brett A Miles; Jeremy D Richmon; Peter E Andersen; Krzysztof J Misiukiewicz; Christine H Chung; Jennifer E Gerber; Shirani D Rajan; Gypsyamber D'Souza
Journal:  JAMA Oncol       Date:  2015-10       Impact factor: 31.777

Review 7.  The role of sexual behavior in head and neck cancer: implications for prevention and therapy.

Authors:  Eleni Rettig; Ana Ponce Kiess; Carole Fakhry
Journal:  Expert Rev Anticancer Ther       Date:  2014-09-05       Impact factor: 4.512

8.  High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.

Authors:  Daniel C Beachler; Yingshi Guo; Wiehong Xiao; Robert D Burk; Howard Minkoff; Howard D Strickler; Ross D Cranston; Dorothy J Wiley; Lisa P Jacobson; Kathleen M Weber; Joseph B Margolick; Elizabeth A Sugar; Susheel Reddy; Maura L Gillison; Gypsyamber D'Souza
Journal:  J Infect Dis       Date:  2015-05-07       Impact factor: 5.226

9.  Multisite HPV infections in the United States (NHANES 2003-2014): An overview and synthesis.

Authors:  Andrew F Brouwer; Marisa C Eisenberg; Thomas E Carey; Rafael Meza
Journal:  Prev Med       Date:  2019-04-05       Impact factor: 4.637

10.  Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance.

Authors:  Arya Amini; Jessica D McDermott; Gregory Gan; Shilpa Bhatia; Whitney Sumner; Christine M Fisher; Antonio Jimeno; Daniel W Bowles; David Raben; Sana D Karam
Journal:  Front Oncol       Date:  2014-10-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.